Synphatec (shanghai) Biopharmaceutical Technology Co., Ltd.

This early-stage trial will test the safety of a new drug called SP-101 in 80 healthy adults aged 18 to 45. Participants will receive either the drug or a placebo by IV, and researchers will monitor side effects and how the drug moves through the body. The study does not aim to t…